Question

Which countries run stem-cell trials for Stroke Recovery?

Sites appear in 22 countries, led by China at about 31% of all country mentions (2026-08-29).

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

Country distribution

CountryStudies with a site there
China28
United States24
Taiwan8
India8
United Kingdom5
France5
Spain4
South Korea4
Malaysia3
United Arab Emirates2

A study with sites in several countries is counted once per country, taken from the location block of each registry record.

What the map means for Stroke Recovery

Registrations follow stroke units with imaging and standardised outcome scoring. Rehabilitation intensity varies enormously between countries, and it is a stronger determinant of recovery than any cell product currently on offer.

Where recruitment is actually open

CountryOpen studies with a site there
China3
United Arab Emirates1
United States1
South Korea1
Indonesia1
Japan1
Antigua and Barbuda1
Argentina1

What travelling for a trial actually involves

Travelling to a trial site is not like booking a treatment package. Sites enrol people they can follow up, which usually means repeated visits over months, local imaging or bloods, and an emergency route if something goes wrong. Ask about all three before booking anything.

Multi-country studies, named

Registered studies with sites in more than one country — the clearest evidence of collaboration rather than a single-centre series.

  • NCT05158101 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for St (Antigua and Barbuda, Argentina)

Why trial geography is not a shortlist

Where studies happen reflects who funds and who authorises them. Treating that as a ranking of care quality confuses the research system with the treatment market, two things that overlap far less than medical-tourism marketing implies.

Before treating geography as a shortlist, read the legality overview by country and what "best country" actually means here.

When these studies started

Registrations by start year since 2020: 2020 (4), 2021 (6), 2022 (4), 2023 (4), 2024 (4), 2025 (7), 2026 (8), 2027 (1). Activity for this condition spans 2005 to 2027, which shows whether interest is growing, flat or past its peak.

Frequently asked

Which countries run stem-cell trials for Stroke Recovery?

Sites are registered in 22 countries; the largest is China (~31% of country mentions, 2026-08-29).

Does a country with many trials mean better treatment there?

It does not follow. A country can host many trials and still have an unregulated commercial sector selling something quite different to visitors.

Are trial sites and commercial clinics the same thing?

Rarely. Academic trial sites and the private clinics advertising to medical tourists are typically separate organisations with different oversight.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads